
Melody Chang, R.Ph., says payers cover bispecific and CAR-T drugs but not the monitoring that lets community practices deliver them safely at lower cost.
The decision of whether or not to expand Medicaid might seem like a cut-and-dried issue, but a closer look indicates that the issue isn't s simple.






